New structure for Singapore Health Sciences Authority
This article was originally published in Scrip
Executive Summary
Singapore's Health Sciences Authority reorganised its structure at the beginning of the month in a move it said was designed to improve collaboration across the organisation. As a result of a review begun last year, three professional groups are responsible for health products regulation (including therapeutic products), blood services (formerly health services) and applied sciences. Comprising various operating divisions, these operate alongside a corporate headquarters under a CEO. The body is a statutory board of Singapore's ministry of health.
You may also be interested in...
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: the shifting sands of pharma R&D; big pharma oncology strategies; semaglutide’s promise in heart failure; AstraZeneca looks to multiple cancer modalities; and an interview with Astellas’s chief strategy officer.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Genmab buys into ADCs; Roivant set to take on AbbVie in uveitis; Ipsen signs firs ADC pact; South Korea looks to build biotech momentum; and the end of the road for Acorda.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Merck & Co progresses cardiovascular strategy; Novo purchase builds heart failure presence; CRL setbacks for Regeneron; ITF faces challenging Duchenne field; and AbbVie needs to freshen up.